Yahoo Web Search

Search results

1. • DAWN (Day One Biopharmaceuticals Inc) may reap gains as insiders became active recently – Knox Daily

     Knox Daily· 3 days ago

     As a result of the transaction, York Charles N II now holds 224,868 shares, worth roughly $2.87 million. Needham reiterated its Day One Biopharmaceuticals Inc [DAWN] rating ...

2. • 

     ArriVent partners Alphamab to develop ADCs for cancer

     Pharmaceutical Technology via Yahoo Finance· 2 days ago

     The partnership will...identifying and developing potential first and best-in-class product...

3. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 4 days ago

     GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings PR Newswire YONGIN, South Korea, June 4, 2024 YONGIN, South Korea, June 4, 2024 /PRNewswire/ -- ...

4. • 

     Biopower Player: Arie Belldegrun

     Los Angeles Business Journal· 5 days ago

     Arie Belldegrun used proceeds from biotech company sales to set up Bellco Capital, which has emerged as the center of a biotech funding and real estate...

5. • Investment Research Library

     Morningstar· 5 days ago

     Morningstar's investment research library contains in-depth insights from hundreds of global analysts on thousands of stocks, funds, bonds, and more.

6. • Small Business - Salisbury Post | Salisbury Post

     The Salisbury Post· 4 days ago

     LabWare Continues to Provide Leadership Through Strategic Partnerships and Innovation in Ireland's BioPharma Sector PR Newswire WILMINGTON, Del., June 4, 2024 WILMINGTON, Del., June 4, 2024 /PRNewswire/ -- LabWare, a global leader in Laboratory

7. • 

     Can Chemo Benefit Older Patients With Pancreatic Cancer?

     Medscape· 1 day ago

     Better tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...

8. • 

     23andMe reports positive phase 2 data for cancer drug By Investing.com

     Investing.com· 5 days ago

     The data was presented at the American Society of Clinical Oncology Annual Meeting, which took place...

9. • 

     Miller: Let’s make the next biotech revolution an American one

     telegraphherald.com· 5 days ago

     Over the years, I have had a front-row seat at the biotech revolution. As a grad student, I did ...

10. • 

      Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...

      The Business Journals· 3 days ago

      ArriVent Biopharma has made a deal with a Chinese firm on a drug development collaboration...